Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bovine C-terminal type I collagen fragments (CTX-I) ELISA Kit-Sandwich

Cat. No.EK9F82

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Bovine CTX-I ELISA Kit-Sandwich is designed for the quantitative determination of Bovine cross linked C-telopeptide of type I collagen (CTX-I) in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Bovine CTX-I.
Target Species Bovine
Species Reactivity Bovine
Detection Range 0.2-10 ng/mL
Sensitivity 0.074 ng/mL
Recovery 85%-108%
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 180 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

C-terminal type I collagen fragments, commonly referred to as CTX-I, serve as a marker for bone resorption in bovine samples. The CTX test detects the presence and concentration of a crosslinked peptide sequence from type I collagen, which is found in bone as well as other tissues.

Target/Biomarker Bovine CTX-I
Target Synonym CTXI; cross linked C-telopeptide of type 1 collagen; cross linked C-telopeptide of type I collagen

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Xian, X. et al. Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells. Stem cell research & therapy. 2020, 11: 179.
Inquiry Basket